CoQ10 & DHEA for Egg Quality: What the Evidence Actually Shows

If you've spent any time in IVF forums or Facebook groups, you've seen CoQ10 and DHEA recommended as near-essential pre-IVF supplements for improving egg quality. Both have plausible biological mechanisms, some supporting studies, and passionate advocates. But the evidence is more nuanced than the enthusiasm suggests — and understanding the actual data helps you make informed decisions with your reproductive endocrinologist rather than following protocol advice from social media.

CoQ10: The Mitochondrial Angle

Coenzyme Q10 is a molecule that plays a central role in mitochondrial energy production — the cellular power generation that oocytes depend on heavily. The biological rationale for CoQ10 supplementation before IVF is compelling: egg maturation, meiotic division, and early embryo development are among the most energy-intensive processes in human biology, and mitochondrial function declines with age.

Animal studies (primarily in mice) have demonstrated that CoQ10 supplementation can restore age-related declines in oocyte quality and mitochondrial function. The question is whether these results translate to human IVF outcomes — and the honest answer is that the human evidence is promising but not definitive.

What human studies show: Several small RCTs and observational studies suggest that CoQ10 supplementation before IVF may improve oocyte quality markers, fertilization rates, and embryo quality in women over 35 or with diminished ovarian reserve. However, most studies are small (under 200 participants), and large confirmatory trials are still lacking. No study has definitively demonstrated improved live birth rates attributable to CoQ10 alone.

DHEA: The Controversial Androgen

Dehydroepiandrosterone (DHEA) is a weak androgen hormone that serves as a precursor to testosterone and estrogen. The hypothesis behind DHEA supplementation before IVF is that androgens play a role in early follicle recruitment and growth — and that supplementing DHEA may increase the number of recruitable follicles in women with diminished ovarian reserve.

DHEA supplementation before IVF was popularized by research from the Center for Human Reproduction in New York, and it's generated more controversy than perhaps any other fertility supplement. The debate isn't about whether DHEA has biological activity (it does) — it's about whether supplementation meaningfully improves IVF outcomes, and for whom.

Evidence Summary

The honest assessment in 2026: neither supplement has Level 1 evidence (large, multicenter RCTs) demonstrating improved live birth rates. Both have biological plausibility and small-study support. CoQ10 has a better safety profile and is more broadly accepted by reproductive endocrinologists. DHEA is more controversial, with benefits that appear limited to specific patient populations (primarily poor responders with diminished ovarian reserve).

Dosing Protocols

CoQ10: Most studies and clinical protocols use 400–600 mg daily of ubiquinol (the reduced, more bioavailable form) or 600–800 mg of ubiquinone (the oxidized form). Ubiquinol is generally preferred for absorption. Take with a fat-containing meal for best absorption.

DHEA: The standard supplementation protocol is 25 mg three times daily (75 mg total), typically as micronized DHEA. Your RE should check baseline DHEA-S and testosterone levels before starting and monitor for androgenic side effects during supplementation.

Who Should Consider Each

CoQ10 may benefit: Women over 35, patients with diminished ovarian reserve (low AMH, low AFC), anyone concerned about egg quality — the risk-benefit ratio is favorable given the excellent safety profile.

DHEA may benefit: Poor responders with genuinely diminished ovarian reserve (POSEIDON groups 3 and 4), particularly those with low DHEA-S levels. It's less likely to benefit patients with normal reserve who simply responded poorly to a particular stimulation protocol.

Neither replaces good medicine: Supplements are adjuncts, not substitutes for proper ovarian stimulation protocols, lab quality, and embryo selection. No supplement compensates for a poorly designed stimulation protocol or an underperforming lab.

How Long Before IVF?

The follicle maturation process takes approximately 90 days — from primordial follicle recruitment to ovulatory follicle. Both CoQ10 and DHEA are typically recommended for a minimum of 8–12 weeks before starting IVF stimulation to allow time for effects on the developing follicle cohort. Starting supplementation one week before your cycle begins is unlikely to produce meaningful benefit.

For medical travelers planning IVF in Colombia, this means beginning supplementation at home well before your planned travel date — coordinate timing with your local RE or the Colombian clinic's remote-consultation process.

Availability in Colombia

CoQ10 supplements are available over the counter at Colombian pharmacies and health-food stores, though selection may be more limited than in the US. DHEA requires more careful sourcing — it's not universally stocked, and pharmaceutical-grade micronized DHEA may be easier to bring from home. Discuss availability with your Colombian fertility clinic during your initial consultation so you can plan accordingly.

Colombian fertility clinics within JCI-accredited hospital systems are familiar with pre-IVF supplementation protocols and can guide you on timing and dosing within the context of your specific treatment plan.

Explore Our Colombia Medical Network